HM13
Signal peptide peptidase
Also known as: dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPP_HUMAN, SPPL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TCT9
- Gene
- HM13
- Ensembl
- ENSG00000101294
- Chromosome
- 20
- Canonical length
- 377 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene, which localizes to the endoplasmic reticulum, catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein. This activity is required to generate signal sequence-derived human lymphocyte antigen-E epitopes that are recognized by the immune system, and to process hepatitis C virus core protein. The encoded protein is an integral membrane protein with sequence motifs characteristic of the presenilin-type aspartic proteases. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>Q8TCT9|HM13
1 MDSALSDPHN GSAEAGGPTN STTRPPSTPE GIALAYGSLL LMALLPIFFG ALRSVRCARG
61 KNASDMPETI TSRDAARFPI IASCTLLGLY LFFKIFSQEY INLLLSMYFF VLGILALSHT
121 ISPFMNKFFP ASFPNRQYQL LFTQGSGENK EEIINYEFDT KDLVCLGLSS IVGVWYLLRK
181 HWIANNLFGL AFSLNGVELL HLNNVSTGCI LLGGLFIYDV FWVFGTNVMV TVAKSFEAPI
241 KLVFPQDLLE KGLEANNFAM LGLGDVVIPG IFIALLLRFD ISLKKNTHTY FYTSFAAYIF
301 GLGLTIFIMH IFKHAQPALL YLVPACIGFP VLVALAKGEV TEMFSYEESN PKDPAAVTES
361 KEGTEASASK GLEKKEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HM13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 222 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 222 nTPM
- salivary gland: 205 nTPM
- esophagus: 116 nTPM
- liver: 115 nTPM
- epididymis: 105 nTPM
- adrenal gland: 94 nTPM
Single-cell type
- esophageal apical cells: 1,457 nCPM
- plasma cells: 497 nCPM
- hofbauer cells: 393 nCPM
- esophageal suprabasal cells: 336 nCPM
- pancreatic acinar cells: 282 nCPM
- syncytiotrophoblasts: 279 nCPM
Immune cell
- classical monocyte: 381 nTPM
- total PBMC: 374 nTPM
- intermediate monocyte: 373 nTPM
- non-classical monocyte: 365 nTPM
- neutrophil: 284 nTPM
- plasmacytoid DC: 272 nTPM
Brain region
- choroid plexus: 103 nTPM
- thalamus: 66 nTPM
- white matter: 58 nTPM
- midbrain: 52 nTPM
- medulla oblongata: 51 nTPM
- pons: 51 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.69
- gnomAD missense Z
- 2.09
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to oxidative stress
- in utero embryonic development
- membrane protein proteolysis
- membrane protein proteolysis involved in retrograde protein transport, ER to cytosol
- signal peptide processing
Molecular functions
- aspartic endopeptidase activity, intramembrane cleaving
- peptidase activity
- protein homodimerization activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HM13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HM13 as an antibody target. Whether an autoantibody or antibody against HM13 could matter depends on whether native HM13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HM13 is annotated at the cell surface, where native HM13 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HM13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...